Metabolic Engineering of Terpenoid Biosynthesis in Medicinal Plants: From Genomic Insights to Biotechnological Applications
Current Issues in Molecular Biology · 05.09.2025 · 47 (9) · 723
DOI: 10.3390/cimb47090723 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 05.09.2025. Verfasst von Changfeng Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Traditional Chinese Medicine Inheritance and Innovation, Guangxi Botanical Garden of Medicinal Plants, Nanning 530012, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangxi Major Science and Technology Special Project, Guangxi Science and Technology Base and Talent Special Project, Guangxi Qihuang Scholars Training Program.
Abstract (Originalsprache)
Terpenoids, which are essential pharmaceutical compounds, encounter significant production challenges due to their low yields in native plants and associated ecological concerns. This review summarizes recent advances in metabolic engineering strategies applied across three complementary platforms: native medicinal plants, microbial systems, and heterologous plant hosts. We present how the “Genomic Insights to Biotechnological Applications” paradigm, supported by multi-omics technologies such as genomics, transcriptomics, metabolomics, and related disciplines, contributes to advancing research in this field. These technologies enable the systematic identification of key biosynthetic genes and regulatory networks. CRISPR-based tools, enzyme engineering, and subcellular targeting are presented as pivotal transformative strategies in advancing metabolic engineering approaches. Strategic co-expression and optimization approaches have achieved substantial improvements in product yields, as demonstrated by a 25-fold increase in paclitaxel production and a 38% enhancement in artemisinin yield. Persistent challenges, such as metabolic flux balancing, cytotoxicity, and scale-up economics, are discussed in conjunction with emerging solutions, including machine learning and photoautotrophic chassis systems. We conclude by proposing a strategic roadmap for industrial translation that highlights the essential integration of systems biology and synthetic biology approaches to accelerate the transition of terpenoid biomanufacturing from discovery to commercial-scale application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Traditional Chinese Medicine Inheritance and Innovation, Guangxi Botanical Garden of Medicinal Plants, Nanning 530012, China.
- School of Life Science and Bioengineering, Jining University, Qufu 273155, China.
ORCID-Profile: Changfeng Guo
Förderung
- Guangxi Major Science and Technology Special Project
- Guangxi Science and Technology Base and Talent Special Project
- Guangxi Qihuang Scholars Training Program
Zitieren
APA
Guo, C., Xu, S., & Guo, X. (2025). Metabolic Engineering of Terpenoid Biosynthesis in Medicinal Plants: From Genomic Insights to Biotechnological Applications. Current Issues in Molecular Biology, 47(9), 723. https://doi.org/10.3390/cimb47090723
Vancouver
Guo C, Xu S, Guo X. Metabolic Engineering of Terpenoid Biosynthesis in Medicinal Plants: From Genomic Insights to Biotechnological Applications. Current Issues in Molecular Biology. 2025;47(9):723. doi:10.3390/cimb47090723
BibTeX
@article{Guo2025,
author = {Guo, Changfeng and Xu, Si and Guo, Xiaoyun},
title = {Metabolic Engineering of Terpenoid Biosynthesis in Medicinal Plants: From Genomic Insights to Biotechnological Applications},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {9},
pages = {723},
doi = {10.3390/cimb47090723}
}
EUVIMED